Transcript segment

Baric Transcribed Interview (Redacted), p.21 · baric_ti:utt:00109

Date: 2026-04-10 09:00 (day precision)
Type: transcript segment · interview
recipient: Christina Salazar, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker: Ralph S. Baric
Topics: Therapeutics and treatments

Let me step back. So historically they published a paper showing that this drug combination might be effective against emerging coronavirus infections, using SARS as their model. We did a head-to-head comparison of remdesivir versus this drug, and had submitted it to Nature Communications for publication. And that was in 2019, and the paper was going to be published on January 10, 2020. On the 7th or so, or on the first call, they wanted me to share that paper with them so that they could evaluate what they were going to do for treating their COVID-19 patients.

Extracted statements

Rule-extracted, not adjudicated. The grade says what may be done with each one; read the document above before relying on any of them.

Statement	Grade	Attribution	Stance
We did a head-to-head comparison of remdesivir versus this drug, and had submitted it to Nature Communications for publication.	own voice, substantive	speaker_own	asserts

Statement

Grade

Attribution

Stance

We did a head-to-head comparison of remdesivir versus this drug, and had submitted it to Nature Communications for publication.

own voice, substantive

speaker_own

asserts

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

2026-04-10 09:00 Ralph S. Baric open

Their cases of SAR-2, of COVID-19, in January of 2020.
2026-04-10 09:00 Christina Salazar open

So they were already publishing a paper.
2026-04-10 09:00 Ralph S. Baric open

No.
2026-04-10 09:00 Christina Salazar open

Okay. I just want to make sure I understand. DC.Scheduling@LexitasLegal.com
2026-04-10 09:00 Ralph S. Baric

Let me step back. So historically they published a paper showing that this drug combination might be effective against emerging coronavirus infections, using SARS as their model. We did a head-to-head comparison of remdesivir versus this drug, and had submitted it to Nature Communications for publication. And that was in 2019, and the paper was going to be published on January 10, 2020. On the 7th or so, or on the first call, they wanted me to share that paper with them so that they could evaluate what they were going to do for treating their COVID-19 patients.
2026-04-10 09:00 Christina Salazar open

At NIH.
2026-04-10 09:00 Ralph S. Baric open

No. China. We didn't have any cases on January 7th, 2020, in the U.S.
2026-04-10 09:00 Christina Salazar open

I just want to make sure I understand. You received information from the Chinese about the SARS16 COVID-2 outbreak.
2026-04-10 09:00 Ralph S. Baric open

I told you that. I think it was around the 4th, that told me it was a coronavirus related to SARS, that was 78 percent identical.

Full conversation →